Could SGLT2 Inhibitors Reduce Rheumatoid Arthritis Flares? Two ACR 2025 analyses link SGLT2 inhibitors to fewer RA flares and a lower risk for osteoarthritis than GLP-1 receptor agonists, though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback